[go: up one dir, main page]

ES2919898B8 - New treatment for colorectal cancer - Google Patents

New treatment for colorectal cancer

Info

Publication number
ES2919898B8
ES2919898B8 ES202130064A ES202130064A ES2919898B8 ES 2919898 B8 ES2919898 B8 ES 2919898B8 ES 202130064 A ES202130064 A ES 202130064A ES 202130064 A ES202130064 A ES 202130064A ES 2919898 B8 ES2919898 B8 ES 2919898B8
Authority
ES
Spain
Prior art keywords
colorectal cancer
new treatment
treatment
new
colorectal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES202130064A
Other languages
Spanish (es)
Other versions
ES2919898A1 (en
ES2919898B2 (en
Inventor
Sanchez Horacio Perez
Martinez Irene Martinez
Garcia Jorge Pena
Bayonas Alberto Carmona
Bleda Maria Del Carmen Rodenas
Martinez Julia Penas
Huesca David Zaragoza
Mendez Victoriano Mulero
Sanchez Irene Pardo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Fundacion Universitaria San Antonio de Cartagena
Original Assignee
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Fundacion Universitaria San Antonio de Cartagena
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia, Fundacion Universitaria San Antonio de Cartagena filed Critical Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Priority to ES202130064A priority Critical patent/ES2919898B8/en
Publication of ES2919898A1 publication Critical patent/ES2919898A1/en
Application granted granted Critical
Publication of ES2919898B2 publication Critical patent/ES2919898B2/en
Publication of ES2919898B8 publication Critical patent/ES2919898B8/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
ES202130064A 2021-01-27 2021-01-27 New treatment for colorectal cancer Active ES2919898B8 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES202130064A ES2919898B8 (en) 2021-01-27 2021-01-27 New treatment for colorectal cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES202130064A ES2919898B8 (en) 2021-01-27 2021-01-27 New treatment for colorectal cancer

Publications (3)

Publication Number Publication Date
ES2919898A1 ES2919898A1 (en) 2022-07-28
ES2919898B2 ES2919898B2 (en) 2023-10-13
ES2919898B8 true ES2919898B8 (en) 2024-02-02

Family

ID=82556716

Family Applications (1)

Application Number Title Priority Date Filing Date
ES202130064A Active ES2919898B8 (en) 2021-01-27 2021-01-27 New treatment for colorectal cancer

Country Status (1)

Country Link
ES (1) ES2919898B8 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024233874A1 (en) * 2023-05-10 2024-11-14 Health Research, Inc. Methods for sequentially administering tas-102 and bcl-2 inhibitor for cancer treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11524009B2 (en) * 2017-10-31 2022-12-13 Eisai R&D Management Co., Ltd. Combination comprising at least one spliceosome modulator and at least one inhibitor chosen from BCL2 inhibitors, BCL2/BCLxL inhibitors, and BCLxL inhibitors and methods of use
JP2021513978A (en) * 2018-02-16 2021-06-03 アッヴィ・インコーポレイテッド Combination of selective BCL-2 inhibitor and anti-PD-1 antibody or anti-PD-L1 antibody in cancer treatment

Also Published As

Publication number Publication date
ES2919898A1 (en) 2022-07-28
ES2919898B2 (en) 2023-10-13

Similar Documents

Publication Publication Date Title
DK4096717T3 (en) CANCER TREATMENT
IL260443B (en) Combinations of anti-egfr for cancer treatment
DK3431105T3 (en) MEDICAL COMPOSITION FOR CANCER TREATMENT
IL260444B (en) Anti-her2 combinations for cancer treatment
CL2018003123A1 (en) Combination therapy for cancer treatment
SMT202200199T1 (en) METHODS OF TREATMENT OF AR+ BREAST CANCER.
HUE049620T2 (en) Methods for treating cancer patients with farnesyltransferase inhibitors
DK3319993T3 (en) AXL-SPECIFIC antibody-drug conjugates for cancer treatment
PL3107541T3 (en) COMPOUNDS FOR TREATMENT OF PATIENTS WITH MUTATED ROS1 CANCER CELLS
KR20180084772A (en) Combination Therapy for Cancer Treatment
EP2968343A4 (en) POLY THERAPY FOR TREATING CANCER
EP3474854A4 (en) CANCER TREATMENT COMBINATIONS
IL265697B1 (en) Prostate cancer treatment
MA44612A (en) PEDIATRIC CANCER TREATMENT METHODS
ES2673209T8 (en) Colorectal Cancer Treatment Procedures
HK1256137A1 (en) Virulence attenuated bacteria for treatment of malignant solid tumors
DK3576740T3 (en) CANCER TREATMENT
IL281845A (en) Combined treatment for cancer
LT3534885T (en) PHARNESYL TRANSANSERASE INHIBITORS FOR THE TREATMENT OF CANCER
IL281600A (en) Cancer treatment methods
IL282478A (en) Materials and methods for cancer treatment
IL281281A (en) Combined treatment for prostate cancer
SG11202010528XA (en) Combinations for treating cancer
EP3484477A4 (en) CANCER TREATMENT
ES2919898B8 (en) New treatment for colorectal cancer

Legal Events

Date Code Title Description
BA2A Patent application published

Ref document number: 2919898

Country of ref document: ES

Kind code of ref document: A1

Effective date: 20220728

FG2A Definitive protection

Ref document number: 2919898

Country of ref document: ES

Kind code of ref document: B2

Effective date: 20231013